Analysis of nasal potential in murine cystic fibrosis models.

[1]  V. Baekelandt,et al.  rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice. , 2016, American journal of respiratory and critical care medicine.

[2]  S. Matalon,et al.  Inter-α-inhibitor blocks epithelial sodium channel activation and decreases nasal potential differences in ΔF508 mice. , 2014, American journal of respiratory cell and molecular biology.

[3]  M. Drumm,et al.  Ventilatory pattern and energy expenditure are altered in cystic fibrosis mice. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[4]  I. Sermet-Gaudelus,et al.  Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice , 2013, PloS one.

[5]  O. Kovbasnjuk,et al.  Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[6]  S. Noel,et al.  PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis , 2012, Front. Pharmacol..

[7]  P. Lebecque,et al.  Comparative Variability of Nasal Potential Difference Measurements in Human and Mice , 2012 .

[8]  G. Lukács,et al.  Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect. , 2012, Human molecular genetics.

[9]  L. Touqui,et al.  Mouse models of cystic fibrosis: phenotypic analysis and research applications. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[10]  M. Rogan,et al.  Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment. , 2011, Chest.

[11]  E. Sorscher,et al.  Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium , 2011, The Laryngoscope.

[12]  E. Sorscher,et al.  Hesperidin stimulates cystic fibrosis transmembrane conductance regulator-mediated chloride secretion and ciliary beat frequency in sinonasal epithelium , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[13]  D. Porteous,et al.  Limitations of the murine nose in the development of nonviral airway gene transfer. , 2010, American journal of respiratory cell and molecular biology.

[14]  D. Parsons,et al.  Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length , 2010, Respiratory research.

[15]  P. Lebecque,et al.  Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice , 2010, European Respiratory Journal.

[16]  D. Schuster,et al.  The bioflavonoid compound, sinupret, stimulates transepithelial chloride transport in vitro and in vivo , 2010, The Laryngoscope.

[17]  Thomas J. Jentsch,et al.  Disruption of the K+ Channel β-Subunit KCNE3 Reveals an Important Role in Intestinal and Tracheal Cl− Transport* , 2010, The Journal of Biological Chemistry.

[18]  J. Escher,et al.  Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. , 2009, Gastroenterology.

[19]  L. Ostrowski,et al.  Ion transport across CF and normal murine olfactory and ciliated epithelium. , 2009, American journal of physiology. Cell physiology.

[20]  P. Lebecque,et al.  Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice. , 2009, American journal of respiratory and critical care medicine.

[21]  B. Harfe,et al.  Transmembrane Protein 16A (TMEM16A) Is a Ca2+-regulated Cl– Secretory Channel in Mouse Airways* , 2009, Journal of Biological Chemistry.

[22]  N. Vij,et al.  Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[23]  Charanjit Singh,et al.  Validation of nasal potential difference measurements in gut-corrected CF knockout mice. , 2008, American journal of respiratory cell and molecular biology.

[24]  P. Lebecque,et al.  Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.

[25]  A. Bush,et al.  Nasal abnormalities in cystic fibrosis mice independent of infection and inflammation. , 2008, American journal of respiratory cell and molecular biology.

[26]  L. Ostrowski,et al.  Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice , 2007, Gene Therapy.

[27]  L. Ostrowski,et al.  Olfactory epithelia exhibit progressive functional and morphological defects in CF mice. , 2007, American journal of physiology. Cell physiology.

[28]  M. D. De Kock,et al.  Successful protocol of anaesthesia for measuring transepithelial nasal potential difference in spontaneously breathing mice , 2006, Laboratory animals.

[29]  M. Schluchter,et al.  Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[30]  J. Bates,et al.  The "Goldilocks Effect" in Cystic Fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse , 2004, BMC Genetics.

[31]  N. Pedemonte,et al.  CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[32]  M. Drumm,et al.  Examining basal chloride transport using the nasal potential difference response in a murine model. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[33]  W. Colledge,et al.  Genistein activates CFTR-mediated Cl(-) secretion in the murine trachea and colon. , 2000, American journal of physiology. Cell physiology.

[34]  H. Ye,et al.  Distribution of ion transport mRNAs throughout murine nose and lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[35]  H. Durrington,et al.  Importance of basolateral K+ conductance in maintaining Cl− secretion in murine nasal and colonic epithelia , 1998, The Journal of physiology.

[36]  L. Tsui,et al.  Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa. , 1998, American journal of respiratory and critical care medicine.

[37]  D. Sheppard,et al.  Comparison of the gating behaviour of human and murine cystic fibrosis transmembrane conductance regulator Cl− channels expressed in mammalian cells , 1998, The Journal of physiology.

[38]  L. Tsui,et al.  Lung disease in mice with cystic fibrosis. , 1997, The Journal of clinical investigation.

[39]  P. French,et al.  A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. , 1996, The Journal of clinical investigation.

[40]  D. Porteous,et al.  Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype‐phenotype correlations. , 1996, The EMBO journal.

[41]  L. Tsui,et al.  Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor , 1996, Nature Genetics.

[42]  K. Thomas,et al.  A mouse model for the delta F508 allele of cystic fibrosis. , 1995, The Journal of clinical investigation.

[43]  H. Morreau,et al.  A mouse model for the cystic fibrosis delta F508 mutation. , 1995, The EMBO journal.

[44]  J. Whitsett,et al.  Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. , 1994, Science.

[45]  James M. Wilson,et al.  Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans , 1994, Nature.

[46]  C. Cotton,et al.  Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Boucher,et al.  CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship , 1993, Nature.

[48]  M. Evans,et al.  Production of a severe cystic fibrosis mutation in mice by gene targeting , 1993, Nature Genetics.

[49]  B. Koller,et al.  An Animal Model for Cystic Fibrosis Made by Gene Targeting , 1992, Science.

[50]  P. Scambler,et al.  Cloning the mouse homolog of the human cystic fibrosis transmembrane conductance regulator gene. , 1991, Genomics.

[51]  L. Tsui,et al.  Physical localization of two DNA markers closely linked to the cystic fibrosis locus by pulsed-field gel electrophoresis. , 1989, American journal of human genetics.

[52]  M. Brennan,et al.  Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas. , 2016, The Journal of molecular diagnostics : JMD.

[53]  L. Tsui,et al.  Erratum: Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor (Nature Genetics (1996) 12 (280-287)) , 1996 .

[54]  D. R. Adams,et al.  Olfactory and non-olfactory epithelia in the nasal cavity of the mouse, Peromyscus. , 1972, The American journal of anatomy.